Skip to main navigation
CareDx
  • COMPANY
    • Management Team
    • Board of Directors
    • Compliance
    • Careers
      • Current Openings
      • Benefits
  • PRODUCTS
    • HeartCare, AlloMap
    • KidneyCare, AlloSure
    • Laboratory Products
    • Ottr
  • INVESTORS
  • CONTACT US

Press Releases

Media Inquiries - media@caredxinc.com
Date Title and Summary Additional Formats
Toggle Summary Nov 17, 2020 CareDx Receives Medicare Reimbursement Pricing for AlloSure Heart
SOUTH SAN FRANCISCO, Calif., Nov. 17, 2020 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers,
View HTML
Toggle Summary Nov 10, 2020 CareDx to Participate at Upcoming Conferences
SOUTH SAN FRANCISCO, Calif., Nov. 10, 2020 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers,
View HTML
Toggle Summary Nov 06, 2020 New Publication Shows CareDx’s AlloSure May Be Effective for Monitoring BK Virus in Transplant Patients
Research from Johns Hopkins , U niversity of Maryland, and Cedars Sinai Shows AlloSure May Signal BK Virus Progression in Transplant Patients SOUTH SAN FRANCISCO, Calif., Nov. 06, 2020 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA), a leading precision medicine company focused on the discovery,
View HTML
Toggle Summary Nov 06, 2020 CareDx Joins National Kidney Foundation in Virtual Walk for Kidney Patients
CareDx’s Chief Marketing Officer Sasha King is the Chair for the Upcoming Pacific Northwest Virtual Kidney Walk SOUTH SAN FRANCISCO, Calif., Nov. 06, 2020 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development, and
View HTML
Toggle Summary Oct 29, 2020 Peter Maag Appointed Executive Chairman of the Board of Directors of CareDx; Reginald Seeto Appointed President and CEO
SOUTH SAN FRANCISCO, Calif., Oct. 29, 2020 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers, today
View HTML
Toggle Summary Oct 29, 2020 CareDx Reports Third Quarter 2020 Results
SOUTH SAN FRANCISCO, Calif., Oct. 29, 2020 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers, today
View HTML
Toggle Summary Oct 21, 2020 CareDx Showcases Leading Transplant Data at ASN 2020
General nephrologists show a growing interest in AlloSure with 11 abstracts and educational symposiums at the largest nephrology meeting SOUTH SAN FRANCISCO, Calif. , Oct. 21, 2020 (GLOBE NEWSWIRE) -- CareDx , Inc. (Nasdaq: CDNA), a leading precision medicine company focused on the discovery,
View HTML
Toggle Summary Oct 19, 2020 Medicare Proposes to Maintain Current Reimbursement Process for AlloMap
CMS believes AlloMap reimbursement process is clinically appropriate for heart transplant patients SOUTH SAN FRANCISCO, Calif. , Oct. 19, 2020 (GLOBE NEWSWIRE) -- CareDx , Inc. (Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development, and commercialization of
View HTML
Toggle Summary Oct 19, 2020 CareDx Leads in Innovation with AlloSeq Portfolio at ASHI 2020
Virtual events to highlight newest innovation and solutions for HLA labs during ASHI conference SOUTH SAN FRANCISCO, Calif. , Oct. 19, 2020 (GLOBE NEWSWIRE) -- CareDx , Inc. (Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development, and commercialization of
View HTML
Toggle Summary Oct 15, 2020 CareDx to Report Third Quarter 2020 Financial Results
SOUTH SAN FRANCISCO, Calif. , Oct. 15, 2020 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers, today
View HTML

Pagination

  • First page First
  • Previous page Previous
  • Page 1
  • Current page 2
  • Page 3
  • Page 4
  • …
  • Next page Next
  • Last page Last
Displaying 11 - 20 of 285 results

Investor Relations

  • Investor Relations
  • Press Releases
  • Events & Presentations
  • Corporate Governance
  • Financials & Filings
  • Stock Information
  • Analyst Coverage
  • Investor FAQs
  • Contact Us

Shareholder Tools

Printed Materials
E-mail Alerts
Downloads
RSS
Print
Share
  • Facebook
  • LinkedIn
  • Twitter
  • RSS

    ©2004-2017 CareDx, Inc. All Rights Reserved.    CareDx is a registered trademark of CareDx, Inc.

    Privacy & Compliance